Complete remission of advanced lung adenocarcinoma with first-line pembrolizumab monotherapy: Two case reports

Immune checkpoint inhibitors (ICIs) are clinically used for treating advanced lung cancer, and some patients have achieved complete remission (CR) with ICI therapy in clinical trials. However, reports summarizing the clinical courses of such patients are limited. We report two cases of lung adenocar...

Descripción completa

Detalles Bibliográficos
Autores principales: Gohara, Kazuki, Okazaki, Akihito, Takeda, Yoshihiro, Iwasa, Keiichi, Shibata, Kazuhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8348966/
https://www.ncbi.nlm.nih.gov/pubmed/34401305
http://dx.doi.org/10.1016/j.rmcr.2021.101469

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8348966/
https://www.ncbi.nlm.nih.gov/pubmed/34401305
http://dx.doi.org/10.1016/j.rmcr.2021.101469

Ejemplares similares